MEDUNIK Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MEDUNIK, and what generic and branded alternatives to MEDUNIK drugs are available?
MEDUNIK has two approved drugs.
Drugs and US Patents for MEDUNIK
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Medunik | NITISINONE | nitisinone | CAPSULE;ORAL | 212390-003 | May 26, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Medunik | PHEBURANE | sodium phenylbutyrate | PELLETS;ORAL | 216513-001 | Jun 17, 2022 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
Medunik | NITISINONE | nitisinone | CAPSULE;ORAL | 212390-002 | May 26, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Medunik | NITISINONE | nitisinone | CAPSULE;ORAL | 212390-004 | Apr 27, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Medunik | NITISINONE | nitisinone | CAPSULE;ORAL | 212390-001 | May 26, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.